TELA Bio, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
TELA Bio, Inc. (TELA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $5.88 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-03-25
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-03-31 was $5.92, a 33.33% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-03-31 was $4.44, a 28.50% decline year-over-year.
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-03-31 was $6.21, a 45.81% decline year-over-year.
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-03-31 was $11.46, a 93.25% increase year-over-year.
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $5.88, a 17.60% increase from fiscal 2023.
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $5.00, a 9.26% decline from fiscal 2022.
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2022 was $5.51, a 22.18% decline from fiscal 2021.
- TELA Bio, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2021 was $7.08, a 12.56% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-12-31 | $5.88 10-K · filed 2026-03-25 | |||
| 2024-09-30 | $5.88 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | $5.88 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | $5.92 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $5.00 10-K · filed 2026-03-25 | |||
| 2023-09-30 | $5.17 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $5.17 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $4.44 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $5.51 10-K · filed 2025-03-21 | |||
| 2022-09-30 | $6.08 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $6.09 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $6.21 10-Q · filed 2022-05-11 | |||
| 2021-12-31 | $7.08 10-K · filed 2024-03-22 | |||
| 2021-09-30 | $7.55 10-Q · filed 2021-11-12 | |||
| 2021-06-30 | $6.70 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $11.46 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | $6.29 10-K · filed 2023-03-23 | |||
| 2020-09-30 | $6.31 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | $6.97 10-Q · filed 2020-08-13 | |||
| 2020-03-31 | $5.93 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | $5.93 10-K · filed 2022-03-23 | |||
| 2019-09-30 | $5.93 10-Q · filed 2019-12-18 | |||
| 2018-12-31 | $5.57 10-K · filed 2021-03-25 | |||
| 2017-12-31 | $5.19 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |